On October 24, 2025, SELLAS Life Sciences Group, Inc. entered into a warrant inducement agreement that allows holders to cash exercise existing warrants for approximately 6.5 million and 15.8 million shares at $1.535 and $1.325, raising about $31 million. The deal includes issuing new warrants for 22.4 million shares at an exercise price of $2.00.